LncRNA DiGeorge syndrome critical region gene 5: A crucial regulator in malignant tumors - 03/09/21
pages | 11 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Long non-coding RNA (lncRNA), a subgroup of ncRNA with a length of more than 200 nt without protein coding function, has been recognized by the academia for its mediating effects of dysregulated expression on the tumorigenesis and development of a variety of tumors. LncRNA DiGeorge syndrome critical region gene 5 (DGCR5), originally found to induce DiGeorge syndrome, has been confirmed to be extremely dysregulated in multiple tumors, which mediates the malignant phenotypes of hepatocellular carcinoma, pancreatic cancer, lung cancer, etc. through the regulation of Wnt/β-catenin, MEK/ERK1/2 and other cancerous signaling pathways as a molecular sponge. Researches on the cancerous derivation-related pathways involved in DGCR5 can provide potential molecular intervention targets for tumor precision treatment. Moreover, liquid biopsy based on the detection of DGCR5 in body fluids is also expected to provide a non-invasive evaluation method for the early diagnosis and prognostic evaluation of malignant tumors.
Le texte complet de cet article est disponible en PDF.Highlights |
• | LncRNAs are potential regulatory sites for cell metabolism and cancerous derivation. |
• | DGCR5 has been confirmed to be abnormally expressed in multiple malignant tumors. |
• | DGCR5 regulates the malignant biological phenotypes of various tumors. |
• | DGCR5 can be used as a potential target for early diagnosis and precise therapy of tumors. |
Abbreviations : BAX, BNIP3, BTG1, ccRCC, ceRNA, CSCs, DGCR5, EGFR, EMT, EPHB6, GEO, GSK-3β, KLF14, lncRNA, NSCLC, PDAC, PDCD4, PTEN, SCLC, TGF-β, TUSC3
Keywords : LncRNA, DGCR5, Regulation mechanism, Diagnostic marker, Liquid biopsy
Plan
Vol 141
Article 111889- septembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?